CIP
BMY icon

Chartwell Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Chartwell Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-53,791
Closed -$3.12M – 423
2023
Q3 		$3.12M Sell
53,791
-97,508
-64% -$5.97M 0.12% 231
2023
Q2 		$9.68M Sell
151,299
-50,063
-25% -$3.36M 0.35% 93
2023
Q1 		$14M Buy
201,362
+5,917
+3% +$417K 0.53% 48
2022
Q4 		$14.1M Sell
195,445
-89,270
-31% -$6.73M 0.55% 41
2022
Q3 		$20.2M Buy
284,715
+1,376
+0.5% +$99.8K 0.86% 10
2022
Q2 		$21.8M Sell
283,339
-37,057
-12% -$2.82M 0.87% 10
2022
Q1 		$23.4M Buy
320,396
+4,707
+1% +$316K 0.78% 12
2021
Q4 		$19.7M Buy
315,689
+23,788
+8% +$1.4M 0.57% 36
2021
Q3 		$17.3M Buy
291,901
+39,927
+16% +$2.63M 0.54% 45
2021
Q2 		$16.8M Sell
251,974
-15,143
-6% -$987K 0.49% 63
2021
Q1 		$16.9M Buy
267,117
+3,985
+2% +$248K 0.5% 65
2020
Q4 		$16.3M Buy
263,132
+10,217
+4% +$628K 0.52% 48
2020
Q3 		$15.2M Sell
252,915
-2,481
-1% -$149K 0.56% 40
2020
Q2 		$15M Buy
255,396
+9,441
+4% +$565K 0.58% 36
2020
Q1 		$13.7M Buy
245,955
+9,434
+4% +$577K 0.64% 32
2019
Q4 		$15.2M Buy
+236,521
New +$13.5M 0.5% 61
2015
Q1 		– Sell
-40,000
Closed -$2.36M – 333
2014
Q4 		$2.36M Hold
40,000
– – 0.05% 305
2014
Q3 		$2.05M Hold
40,000
– – 0.05% 298
2014
Q2 		$1.94M Hold
40,000
– – 0.04% 296
2014
Q1 		$2.08M Sell
40,000
-40,000
-50% -$2.13M 0.04% 293
2013
Q4 		$4.25M Sell
80,000
-13,100
-14% -$667K 0.09% 257
2013
Q3 		$4.31M Buy
93,100
+13,100
+16% +$575K 0.1% 254
2013
Q2 		$3.58M Buy
+80,000
New +$3.47M 0.09% 264

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Chartwell Investment Partners's BMY Position: Q4 2023 in Review

Chartwell Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 53,791 shares — an estimated $3.12M sold.

Chartwell Investment Partners first reported a position in BMY in Q2 2013 and held it in 23 quarters. The position peaked at $23.4M in Q1 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Chartwell Investment Partners reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Chartwell Investment Partners sold 53,791 Bristol-Myers Squibb shares in Q4 2023, an estimated $3.12M.
  • Chartwell Investment Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 23 quarters.
  • Chartwell Investment Partners's Bristol-Myers Squibb position peaked at $23.4M in Q1 2022.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Chartwell Investment Partners's 13F filing for Q4 2023, filed 15 Feb 2024.